High metallothionein predicts poor survival in glioblastoma multiforme

BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor. Even with vigorous surgery, radiation and chemotherapy treatment, survival rates of GBM are very poor and predictive markers for prognosis are currently lacking. METHODS: We performed whole genome expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrian-Shai, Ruty, Yalon, Michal, Simon, Amos J., Eyal, Eran, Pismenyuk, Tatyana, Moshe, Itai, Constantini, Shlomi, Toren, Amos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618994/
https://www.ncbi.nlm.nih.gov/pubmed/26493598
http://dx.doi.org/10.1186/s12920-015-0137-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618994/
https://www.ncbi.nlm.nih.gov/pubmed/26493598
http://dx.doi.org/10.1186/s12920-015-0137-6

Ejemplares similares